Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -36.51% is 80% above its 5-year average of -185.48%, near the high end of its 5-year range (-17030.75%–4286.30%).
60.76% below its 12-month average of -22.71%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -63.17%.
NET PROFIT MARGIN
-36.51%
NET PROFIT MARGIN AVG TTM
-22.71%
NET PROFIT MARGIN AVG 3Y
-5.94%
NET PROFIT MARGIN AVG 5Y
-185.48%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-60.76%
CURRENT VS 3Y AVG
-514.33%
CURRENT VS 5Y AVG
+80.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 509 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$2.06B
Net Profit Margin
15.03%
TTM Avg
11.31%
3Y Avg
2.06%
5Y Avg
-9.89%
Market Cap
$2.04B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$2.05B
Net Profit Margin
-40.90%
TTM Avg
5.22%
3Y Avg
-37.29%
5Y Avg
-215.44%
Market Cap
$2.02B
Net Profit Margin
100.84%
TTM Avg
51.96%
3Y Avg
-5.31%
5Y Avg
-103.82%
Market Cap
$2.09B
Net Profit Margin
-3.18%
TTM Avg
-24.20%
3Y Avg
-10.68%
5Y Avg
-8.90%
Market Cap
$2.05B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$2.02B
Net Profit Margin
-13.36%
TTM Avg
-6.14%
3Y Avg
-11.71%
5Y Avg
-14.87%
Market Cap
$1.99B
Net Profit Margin
-7756.37%
TTM Avg
-3193.87%
3Y Avg
-2536.69%
5Y Avg
-2093.05%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alvotech (ALVO) | $2.04B | -36.51% | -22.71% | -5.94% | -185.48% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.06B | 15.03% | 11.31% | 2.06% | -9.89% |
| Immunome, Inc. (IMNM)vs › | $2.04B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.05B | -40.90% | 5.22% | -37.29% | -215.44% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 100.84% | 51.96% | -5.31% | -103.82% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.09B | -3.18% | -24.20% | -10.68% | -8.90% |
| Azenta, Inc. (AZTA)vs › | $2.05B | -20.02% | -19.08% | -29.38% | -13.21% |
| AxoGen, Inc. (AXGN)vs › | $2.02B | -13.36% | -6.14% | -11.71% | -14.87% |
| Absci Corporation (ABSI)vs › | $1.99B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
| Addus HomeCare Corporation (ADUS)vs › | $2.12B | 7.13% | 6.55% | 5.96% | 5.57% |
Operating Margin
9.6%
Net Profit Margin
-36.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -63.17% |
| 2026-03-31 | 0.97% |
| 2025-12-31 | -65.27% |
| 2025-09-30 | -4.58% |
| 2025-06-30 | 18.49% |
| 2025-03-31 | 82.61% |
| 2024-12-31 | -44.29% |
| 2024-09-30 | -11.07% |
| 2024-06-30 | 32.82% |
| 2024-03-31 | -593.53% |
| 2023-12-31 | -517.99% |
| 2023-08-31 | -1058.63% |
| 2023-06-30 | 4286.30% |
| 2023-03-31 | -1740.92% |
| 2022-12-31 | -1343.39% |
| 2022-09-30 | -45.15% |
| 2022-06-30 | -270.99% |
| 2022-03-31 | -17030.75% |
| 2021-12-31 | 729.94% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -11627.63% |
| 2021-03-31 | -11627.63% |
| 2020-12-31 | -55.46% |
| 2020-09-30 | -255.26% |
| 2020-06-30 | -255.26% |
| 2020-03-31 | -255.26% |
| 2019-12-31 | -657.55% |
| 2019-09-30 | -657.55% |
| 2019-06-30 | -657.55% |
| 2019-03-31 | -657.55% |
